Clinical Trial Update: A Phase III Study of SP2086 in Combination With Metformin in Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase III clinical trial is evaluating SP2086 in combination with metformin for Type 2 diabetes; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SP2086
• metformin (metformin)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Type 2 Diabetes | Phase 3 | Status: UNKNOWN